Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan

被引:123
作者
Ohno, H
Koga, H
Kohno, S
Tashiro, T
Hara, K
机构
关键词
D O I
10.1128/AAC.40.4.1053
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We analyzed the relationship between rifampin MICs and rpoB mutations of 40 clinical isolates of Mycobacterium tuberculosis. A point mutation in either codon 516, 526, or 531 was found in 13 strains requiring MICs of greater than or equal to 64 mu g/ml, while 21 strains requiring MICs of less than or equal to 1 mu g/ml showed no alteration in these codons. However 3 of these 21 strains contained a point mutation in either codon 515 or 533. Of the other six strains requiring MICs between 2 and 32 mu g/ml, three contained a point mutation in codon 516 or 526, while no alteration was detected in the other three. Our results indicate that the sequencing analysis of a 69-bp fragment in the rpoB gene is useful in predicting rifampin-resistant phenotypes.
引用
收藏
页码:1053 / 1056
页数:4
相关论文
共 27 条
[1]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[2]   MUTATION POSITION AND TYPE OF SUBSTITUTION IN THE BETA-SUBUNIT OF THE RNA-POLYMERASE INFLUENCE IN-VITRO ACTIVITY OF RIFAMYCINS IN RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS [J].
BODMER, T ;
ZURCHER, G ;
IMBODEN, P ;
TELENTI, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) :345-348
[3]   SCREENING OF RESPIRATORY-TRACT SPECIMENS FOR THE PRESENCE OF MYCOBACTERIUM-TUBERCULOSIS BY USING THE GEN-PROBE AMPLIFIED MYCOBACTERIUM-TUBERCULOSIS DIRECT TEST [J].
BODMER, T ;
GURTNER, A ;
SCHOPFER, K ;
MATTER, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (06) :1483-1487
[4]   AN OUTBREAK OF MULTIDRUG-RESISTANT TUBERCULOSIS AMONG HOSPITALIZED-PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
EDLIN, BR ;
TOKARS, JI ;
GRIECO, MH ;
CRAWFORD, JT ;
WILLIAMS, J ;
SORDILLO, EM ;
ONG, KR ;
KILBURN, JO ;
DOOLEY, SW ;
CASTRO, KG ;
JARVIS, WR ;
HOLMBERG, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (23) :1514-1521
[5]   THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY [J].
FRIEDEN, TR ;
STERLING, T ;
PABLOSMENDEZ, A ;
KILBURN, JO ;
CAUTHEN, GM ;
DOOLEY, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :521-526
[6]   STREPTOMYCIN RESISTANCE IN MYCOBACTERIA [J].
HONORE, N ;
COLE, ST .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :238-242
[7]  
KAPUR V, 1995, ARCH PATHOL LAB MED, V119, P131
[8]   IS MYCOBACTERIUM-TUBERCULOSIS 15,000 YEARS OLD [J].
KAPUR, V ;
WHITTAM, TS ;
MUSSER, JM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1348-1349
[9]   CHARACTERIZATION BY AUTOMATED DNA-SEQUENCING OF MUTATIONS IN THE GENE (RPOB) ENCODING THE RNA-POLYMERASE BETA-SUBUNIT IN RIFAMPIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS STRAINS FROM NEW-YORK-CITY AND TEXAS [J].
KAPUR, V ;
LI, LL ;
IORDANESCU, S ;
HAMRICK, MR ;
WANGER, A ;
KREISWIRTH, BN ;
MUSSER, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) :1095-1098
[10]   DEVELOPMENT OF A RAPID METHOD FOR DETERMINING THE SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO ISONIAZID USING THE GEN-PROBE DNA HYBRIDIZATION SYSTEM [J].
KAWA, DE ;
PENNELL, DR ;
KUBISTA, LN ;
SCHELL, RF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1000-1005